sevoflurane but not propofol preserves myocardial function in coronary surgery patients. Anesthesiology. 2002;97:42 9. 224. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its adminis- tration. Anesthesiology. 2004;101:299 310. 225. De Hert SG, Van der Linden PJ, Cromheecke S, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthe- siology. 2004;101:9 20. 226. Garcia C, Julier K, Bestmann L, et al. Preconditioning with sevoflurane decreases PECAM-1 expression and improves one-year cardiovascular outcome in coronary artery bypass graft surgery. Br J Anaesth. 2005; 94:159 65. 227. Julier K, da Silva R, Garcia C, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo- controlled, multicenter study. Anesthesiology. 2003;98:1315 27. 228. Fillinger MP, Surgenor SD, Hartman GS, et al. The association between heart rate and in-hospital mortality after coronary artery bypass graft surgery. Anesth Analg. 2002;95:1483 8. 229. Fox K, Ford I, Steg PG, et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dys- function (BEAUTIFUL): a subgroup analysis of a randomised con- trolled trial. Lancet. 2008;372:817 21. 230. Breisblatt WM, Stein KL, Wolfe CJ, et al. Acute myocardial dys- function and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15:1261 9. 231. Ekery DL, Davidoff R, Orlandi QG, et al. Imaging and diagnostic testing: diastolic dysfunction after coronary artery bypass grafting: a frequent finding of clinical significance not influenced by intravenous calcium. Am Heart J. 2003;145:896 902. 232. Bijker JB, van Klei WA, Kappen TH, et al. 